Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (5)

2021

  1. Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial

    Radiotherapy and Oncology, Vol. 160, pp. 115-119

2016

  1. Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial

    International Journal of Radiation Oncology Biology Physics, Vol. 96, Núm. 2, pp. 341-348

2015

  1. High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): A randomised, controlled, phase 3 trial

    The Lancet Oncology, Vol. 16, Núm. 3, pp. 320-327

2014

  1. Infrastructures, treatment modalities, and workload of radiation oncology departments in Spain with special attention to prostate cancer

    Clinical and Translational Oncology, Vol. 16, Núm. 5, pp. 447-454

2006

  1. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation

    International Journal of Radiation Oncology Biology Physics, Vol. 64, Núm. 4, pp. 1122-1128